4.6 Review

TGF-β Sustains Tumor Progression through Biochemical and Mechanical Signal Transduction

Journal

CANCERS
Volume 10, Issue 6, Pages -

Publisher

MDPI
DOI: 10.3390/cancers10060199

Keywords

TGF-beta; cancer; immunosuppression; TAK1; mechanobiology; extracellular matrix; tensegrity; DNA damage

Categories

Funding

  1. District of Columbia Center for AIDS Research
  2. NIH [AI117970]
  3. NIAID
  4. NCI
  5. NICHD
  6. NHLBI
  7. NIDA
  8. NIMH
  9. NIA
  10. FIC
  11. NIGMS
  12. NIDDK
  13. OAR
  14. UCLA AIDS Institute
  15. UCLA CFAR NIH [AI-28697]
  16. James B. Pendleton Charitable Trust
  17. McCarthy Family Foundation
  18. NIH

Ask authors/readers for more resources

Transforming growth factor beta (TGF-beta) signaling transduces immunosuppressive biochemical and mechanical signals in the tumor microenvironment. In addition to canonical SMAD transcription factor signaling, TGF-beta can promote tumor growth and survival by inhibiting proinflammatory signaling and extracellular matrix (ECM) remodeling. In this article, we review how TGF-beta activated kinase 1 (TAK1) activation lies at the intersection of proinflammatory signaling by immune receptors and anti-inflammatory signaling by TGF-beta receptors. Additionally, we discuss the role of TGF-beta in the mechanobiology of cancer. Understanding how TGF-beta dampens proinflammatory responses and induces pro-survival mechanical signals throughout cancer development is critical for designing therapeutics that inhibit tumor progression while bolstering the immune response.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available